These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 20843840)
1. Regenerative medicine: the emergence of an industry. Nerem RM J R Soc Interface; 2010 Dec; 7 Suppl 6(Suppl 6):S771-5. PubMed ID: 20843840 [TBL] [Abstract][Full Text] [Related]
2. 2010 lifetime achievement award of Tissue Engineering and Regenerative Medicine International Society--north America: Arnold I. Caplan, Ph.D. Caplan AI Tissue Eng Part A; 2011 Feb; 17(3-4):267. PubMed ID: 21128820 [No Abstract] [Full Text] [Related]
3. Tissue engineering and regenerative medicine: from first principles to state of the art. Vacanti J J Pediatr Surg; 2010 Feb; 45(2):291-4. PubMed ID: 20152338 [TBL] [Abstract][Full Text] [Related]
4. Regenerative medicine: then and now--an update of recent history into future possibilities. Polykandriotis E; Popescu LM; Horch RE J Cell Mol Med; 2010 Oct; 14(10):2350-8. PubMed ID: 20825521 [TBL] [Abstract][Full Text] [Related]
5. On the genealogy of tissue engineering and regenerative medicine. Kaul H; Ventikos Y Tissue Eng Part B Rev; 2015 Apr; 21(2):203-17. PubMed ID: 25343302 [TBL] [Abstract][Full Text] [Related]
6. The Netherlands advancing to the forefront of regenerative medicine. Gielen K Stem Cells Dev; 2014 Dec; 23 Suppl 1():29-31. PubMed ID: 25457958 [TBL] [Abstract][Full Text] [Related]
7. Regenerative medicine: the last 10 years. Lanza R Regen Med; 2016 Dec; 11(8):745-746. PubMed ID: 27911242 [No Abstract] [Full Text] [Related]
8. Tissue engineering and regenerative medicine: history, progress, and challenges. Berthiaume F; Maguire TJ; Yarmush ML Annu Rev Chem Biomol Eng; 2011; 2():403-30. PubMed ID: 22432625 [TBL] [Abstract][Full Text] [Related]
9. Yoshiki Sasai 1962–2014. De Robertis EM Dev Cell; 2014 Sep; 30(5):509-11. PubMed ID: 25340213 [No Abstract] [Full Text] [Related]
11. Hurdles in tissue engineering/regenerative medicine product commercialization: a pilot survey of governmental funding agencies and the financial industry. Bertram TA; Tentoff E; Johnson PC; Tawil B; Van Dyke M; Hellman KB Tissue Eng Part A; 2012 Nov; 18(21-22):2187-94. PubMed ID: 22838399 [TBL] [Abstract][Full Text] [Related]
12. Cell therapy--back on the up-curve. Interview with Paul Kemp by Elisa Manzotti. Kemp P Regen Med; 2006 Jan; 1(1):9-14. PubMed ID: 17465816 [TBL] [Abstract][Full Text] [Related]
13. Anthony Atala: at the cutting edge of regenerative surgery. Pincock S Lancet; 2011 Oct; 378(9800):1371. PubMed ID: 22000126 [No Abstract] [Full Text] [Related]
14. The impact of biomechanics in tissue engineering and regenerative medicine. Butler DL; Goldstein SA; Guldberg RE; Guo XE; Kamm R; Laurencin CT; McIntire LV; Mow VC; Nerem RM; Sah RL; Soslowsky LJ; Spilker RL; Tranquillo RT Tissue Eng Part B Rev; 2009 Dec; 15(4):477-84. PubMed ID: 19583462 [TBL] [Abstract][Full Text] [Related]
15. Centre for Commercialization of Regenerative Medicine: moving forward with regenerative medicine commercialization in Canada. Johnson S Stem Cells Dev; 2013 Dec; 22 Suppl 1():85-8. PubMed ID: 24304082 [No Abstract] [Full Text] [Related]
18. Tissue engineering/regenerative medicine ventures should invest early in market research to understand the future market's needs. Gemmiti C Tissue Eng Part B Rev; 2013 Apr; 19(2):97-8. PubMed ID: 23327734 [No Abstract] [Full Text] [Related]
19. Doris A. Taylor, PhD, Hon DSc: Director, Regenerative Medicine Research, Director, Center for Cell and Organ Biotechnology at Texas Heart Institute and Texas A&M University. Transplantation; 2018 Dec; 102(12):1963-1965. PubMed ID: 30461728 [No Abstract] [Full Text] [Related]
20. Chasing the Paradigm: Clinical Translation of 25 Years of Tissue Engineering. Hoffman T; Khademhosseini A; Langer R Tissue Eng Part A; 2019 May; 25(9-10):679-687. PubMed ID: 30727841 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]